This patent application is assigned to Proteus Digital Health, Inc. The following quote was obtained by the news editors from the background information supplied by the inventors: “Multiple therapies ...
BERLIN--(BUSINESS WIRE)--Booster Therapeutics, a biotechnology company pioneering a new class of proteasome activator medicines to treat neurodegenerative and other diseases, launched today with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback